Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Mainz Biomed NV
MYNZ
Healthcare
Medical Care
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of...
pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:MYNZ)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(38)
•••
Trader19Swift
X
View Profile
View Bullboard History
Post by
Trader19Swift
on Nov 26, 2024 12:42pm
Trend Trading Alert: MYNZ Bouncing Off Key Levels
Trend traders should note MYNZ's support levels—it’s bouncing where bulls typically step in.
(23)
•••
TradeVision2001
X
View Profile
View Bullboard History
Comment by
TradeVision2001
on Nov 25, 2024 12:14pm
RE:Vanguard & Blackrock Holding TMO – MYNZ Next?
Big money never lies! If MYNZ is catching the eye of the giants, I’m all in. This could be the next big runner!
(23)
•••
TradeVision2001
X
View Profile
View Bullboard History
Post by
TradeVision2001
on Nov 25, 2024 12:11pm
Swing Traders’ Biotech Dream: MYNZ Catalyst Potential
Swing traders, don’t sleep on MYNZ. Those biotech catalysts can drop news and spike the chart any day.
(4)
•••
WealthSpring16
X
View Profile
View Bullboard History
Post by
WealthSpring16
on Nov 25, 2024 11:42am
Biotech Tailwinds: Sector in Focus
Biotech’s heating up, and MYNZ is looking primed to ride sector tailwinds. A strategic add for those bullish on health tech.
(5)
•••
pastafagoli
X
View Profile
View Bullboard History
Post by
pastafagoli
on Nov 23, 2024 10:59am
Why stock is droppping
They withdrew their submission from FDA for breakthrough device designation after the FDA told them to expand trials for average risk particpants. New data to be submitted in 2025. Lots of
...more
(2)
•••
TradeDriver718
X
View Profile
View Bullboard History
Post by
TradeDriver718
on Nov 22, 2024 3:55pm
Mainz Biomed: Unlocking the Future of Diagnostics
With its low float and groundbreaking technology, MYNZ is a compelling play in the diagnostics space. Its ability to address an unmet global health need gives it a unique position for long-term growth
...more
(5)
•••
pastafagoli
X
View Profile
View Bullboard History
Post by
pastafagoli
on Nov 22, 2024 10:38am
new to this company
Just looked at June 30 2024 FS. Going concern disclosure as expected. Used 7M in cash in 6 mos. Had 700K at June 30. Anyone know other than mass share dilution how they are
...more
(44)
•••
MarketWolf2024
X
View Profile
View Bullboard History
Post by
MarketWolf2024
on Nov 20, 2024 7:01am
Mainz Biomed NV (MYNZ)
I’m considering a stock to buy for a few years. I see potential because the company has serious intentions, especially after the latest news.
(5)
•••
Vic2Trader1
X
View Profile
View Bullboard History
Post by
Vic2Trader1
on Nov 19, 2024 3:05pm
$MYNZ & $TMO Partnership LFGOOO
TMO 507.78 +6.49(+1.29%) Volume 2,203,357 (2x avg) Zack Analyst Highlighted Thermo Fisher $TMO NextEra Energy $NEE and Lowe's $LOW https://finance.yahoo
...more
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Oct 01, 2024 1:15pm
Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eye
Just In: $MYNZ Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025BERKELEY, Calif. and MAINZ, Germany, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed
...more
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on May 28, 2024 12:30pm
Mainz Biomed to Present New Pooled Colorectal Cancer Screeni
JUST IN: $MYNZ Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting | BenzingaKey Findings: 92.3% Sensitivity for Colorectal
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Do you want to stay ahead of the markets? See how DealRoom can help.